About Arivale
Arivale is a company based in Seattle (United States) founded in 2014. Arivale has raised $49.6 million across 2 funding rounds from investors including Arch Venture Partners, Polaris Partners and Maveron. Arivale operates in a competitive market with competitors including Helix, Counsyl, InformedDNA, Digbi Health and MyOme, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Arivale Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$49.6 M (USD)
in 2 rounds
-
Latest Funding Round
$13.6 M (USD), Series C
Jun 13, 2017
-
Investors
Arch Venture Partners
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Arivale
Arivale has successfully raised a total of $49.6M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $13.6 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $13.6M
-
First Round
First Round
(14 Jul 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Series C - Arivale | Valuation |
investors |
|
| Jul, 2015 | Amount | Series B - Arivale | Valuation | Maveron |
Investors in Arivale
Arivale has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Venture Partners, Polaris Partners and Maveron.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Venture capital investments in consumer businesses, emphasizing technology and human behavior.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Arivale
Financial Statements - Arivale
Arivale Comparisons
Competitors of Arivale
Arivale operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Counsyl, InformedDNA, Digbi Health and MyOme, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| domain | founded_year | HQ Location |
Network of genetics experts provided to assist patients and providers.
|
|
| domain | founded_year | HQ Location |
Personalized healthcare is delivered through DNA and gut biome testing.
|
|
| domain | founded_year | HQ Location |
Provider of a platform for gene analysis to determine genetic diseases and drug response
|
Frequently Asked Questions about Arivale
Arivale was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Arivale is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Arivale is a funded company, having raised a total of $49.6M across 2 funding rounds to date. The company's 1st funding round was a Series B of $36M, raised on Jul 14, 2015.
Arivale was established in 2014 in Seattle, United States, within the bioscience sector. Testing of consumers genomes, blood, saliva, gut microbiomes, and lifestyles is conducted through direct-to-consumer services. Data from these analyses is processed to deliver tailored fitness and nutritional guidance. Operations focus on integrating genetic, clinical, and environmental factors for individualized health insights, with biotech pioneer Lee Hood among the founders.
Arivale's top competitors include Helix, Digbi Health and InformedDNA.
Arivale has 3 investors. Key investors include Arch Venture Partners, Polaris Partners, and Maveron.